Stock GANX GAIN THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Gain Therapeutics, Inc.

Equities

GANX

US36269B1052

Real-time Estimate Cboe BZX
Other stock markets
 10:05:20 2024-06-10 am EDT 		5-day change 1st Jan Change
2.265 USD +2.95% Intraday chart for Gain Therapeutics, Inc. -5.26% -28.33%
May. 14 Gain Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 24 Gain Therapeutics, Inc. Announces Positive Results from the Single Ascending Dose Part of the Phase 1 Clinical Trial of GT-02287 CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. GANX Stock
  4. Revisions Gain Therapeutics, Inc.